Jordan Park

Jordan Park

Healthcare & Biotech Analyst

Healthcare and biotech analyst focused on pharma pipelines, medtech adoption curves, and reimbursement dynamics. Former clinical research coordinator and later equity research analyst. Writes thesis-driven pieces that connect clinical catalysts, competitive landscapes, and valuation scenarios.

Articles 769

Dec 28, 2025 Finance

Three Growth-Oriented Stocks Poised for Long-Term Expansion Through the 2030s

Examining Amazon, Vertex Pharmaceuticals, and TJX Companies for sustained growth potential

Investors seeking growth opportunities to hold through the next decade may consider companies demonstrating strong financial performance, innovative b...

Dec 28, 2025 Finance

Walmart's Resilience: A Retail Stock Worth Holding Through Market Fluctuations

Examining Walmart's Enduring Strength Amid Economic Challenges and Market Volatility

Walmart has demonstrated consistent resilience through various economic downturns and market recessions, maintaining strong performance relative to th...

Dec 28, 2025 Finance

Stonepine Capital Reduces Indivior Stake Despite Strong Stock Performance

Investor trims position following a nearly 200% surge in Indivior shares amid improving business fundamentals

Stonepine Capital Management has decreased its holding in Indivior PLC by 250,000 shares, valued around $2.75 million, according to recent SEC filings...

Mastering Stock Trading Beta: Understanding and Applying Beta to Manage Market Risk Effectively
Dec 28, 2025 Education

Mastering Stock Trading Beta: Understanding and Applying Beta to Manage Market Risk Effectively

For beginner and intermediate traders seeking to use stock beta to assess risk and improve portfolio decisions

Beta is a key metric that measures how sensitive a stock's price is relative to overall market movements. This guide explains what beta means, how to ...

Farewell to the MetroCard: New York Transitions to a Contactless Subway Payment Era
Dec 28, 2025 News & Politics

Farewell to the MetroCard: New York Transitions to a Contactless Subway Payment Era

After Over 30 Years, the Iconic Fare Card Is Phased Out in Favor of OMNY Tap-and-Go System

Since its introduction in 1994 replacing the subway token, the MetroCard has been a defining feature of New York City's transit system. As the Metropo...

Mastering Swing Trading: A Step-by-Step Guide for Beginner and Intermediate Stock Traders
Dec 28, 2025 Education

Mastering Swing Trading: A Step-by-Step Guide for Beginner and Intermediate Stock Traders

For traders aiming to understand and apply swing trading techniques with clear strategies, risk management, and practical examples

Swing trading focuses on capturing medium-term stock price moves by holding positions for several days to weeks. This comprehensive guide explains the...

Dec 28, 2025 Finance

Potential Rebound Candidates in the Stock Market for 2026

Examining The Trade Desk and PayPal's Positions for a Possible Market Recovery

Investors looking toward 2026 may find opportunity in stocks that have underperformed in 2025, provided these stocks have solid fundamentals and plaus...

Reviving the Analog Way: Finding Solace Beyond Digital Dominance
Dec 28, 2025 News & Politics

Reviving the Analog Way: Finding Solace Beyond Digital Dominance

In a digital-dominated era, many seek tangible connections through traditional activities and formats

In an age overwhelmingly shaped by digital technology, significant numbers of people across generations are deliberately turning to analog pursuits su...

Dec 28, 2025 Finance

Cruiser Capital Adds Significant Stake in TIC Solutions Following Strategic Merger

Investment Fund's New Equity Position Highlights Confidence in TIC Solutions' Growth Prospects Amidst Merger Completion

Cruiser Capital Advisors has initiated a substantial equity position in TIC Solutions, acquiring over 200,000 shares valued at approximately $2.76 mil...

Dec 27, 2025 Trade Ideas

Why I Keep Buying Adobe After Q3 - Accumulate on Strength, Not on Hope

Strong margins, reliable cash flow and AI product optionality make Adobe a buy-after-earnings for patient, risk-aware investors.

Adobe reported another quarter of steady revenue and best-in-class margins, with Q3 FY2025 revenue of $5.988B, operating income of $2.173B and diluted...

Trade Idea Long